Total number of publications: 79
2026
-
Imunoterapie checkpoint inhibitory indikovaná podle doporučení molekulárního tumor boardu na základě hodnoty nádorové mutační nálože (TMB): Reálné výsledky z české národní platformy precizní onkologie GENESIS
Year: 2026, type: Conference abstract
-
Molekulární profily a genomicky řízená léčba GI nádorů u mladých dospělých vs. pacientů s průměrným věkem nástupu nemoci: data české národní sítě precizní medicíny GENESIS
Year: 2026, type: Appeared in Conference without Proceedings
-
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysis
European Journal of Cancer, year: 2026, volume: 232, edition: January 2026, DOI
2025
-
10. setkání CZECRIN ONCO
Year: 2025, type: Workshop
-
157P Real-world outcomes of checkpoint inhibitors guided by molecular testing and tumor mutation burden (TMB): Results from Czech national precision medicine network study GENESIS
Year: 2025, type: Conference abstract
-
496P Fertility preservation practices at gastrointestinal (GI) oncology in Europe: A Pan-European study
Year: 2025, type: Conference abstract
-
9. setkání CZECRIN ONCO
Year: 2025, type: Workshop
-
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypND and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
Annals of Oncology, year: 2025, volume: 36, edition: 2, DOI
-
ESMO Clinical Practice Guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma
ESMO OPEN, year: 2025, volume: 10, edition: 2, DOI
-
Fertility preservation practices and gastrointestinal oncologist in Europe: a pan-European study
Oncologist, year: 2025, volume: 30, edition: 11, DOI